Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$400.86 USD
+6.58 (1.67%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $399.92 -0.94 (-0.23%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (86 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.87 | 1.35 | 9.99 |
Current Quarter Estimate | 4.10 | 7.43 | 60.00 |
Year Ago Quarter Estimate | 3.05 | 0.12 | 52.54 |
Next Quarter Estimate | 4.08 | 7.81 | 61.00 |
Next Year Estimate | 18.00 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 10.05 | 13.30 | 17.08 |
Next Year | 7.40 | 7.80 | 8.00 |
Last 5 Years | 38.20 | 1.00 | 8.10 |
Next 5 Years | 14.20 | 20.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 25.91 | -2.18 |
Price/Book (MRQ) | 5.78 | 2.22 |
Price/Cash Flow (MRFY) | 26.90 | 15.70 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 36.68% | -100.99% |
Return on Equity (TTM) | 21.91% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.